GoalVest Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
GoalVest Advisory's PFE Position: Q2 2026 in Review
GoalVest Advisory reduced its Pfizer (PFE) stake by 54% in Q2 2026, selling an estimated $28.9K and leaving 924 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #293.
GoalVest Advisory first reported a position in PFE in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- GoalVest Advisory held 924 shares of Pfizer worth $22.3K as of Q2 2026.
- GoalVest Advisory sold 1,104 Pfizer shares in Q2 2026, an estimated $28.9K.
- Pfizer made up ﹤0.01% of GoalVest Advisory's portfolio in Q2 2026, its #293 holding.
- GoalVest Advisory first reported a position in Pfizer in Q2 2021 and has held it in 19 quarters since.
- GoalVest Advisory's Pfizer position peaked at $1.48M in Q4 2022.
- 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.